Reduced Inflammatory Activity in Atherosclerotic Plaques after Peptide Receptor-Targeted Radionuclide Therapy Detected by [68Ga]Ga-DOTATOC PET

被引：0
|
作者：
Kosmala, Aleksander
Weich, Alexander
Serfling, Sebastian
Schlotelburg, Wiebke
Michalski, Kerstin
Meining, Alexander
Higuchi, Takahiro
Buck, Andreas
Werner, Rudolf
Hartrampf, Philipp
机构：
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
242046
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Does Molecular Response Assessment after Peptide Receptor Radionuclide Therapy using Ga-68 Somatostatin Receptor PET/CT Offer an Additional Benefit?
    Kulkarni, H. R.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S200 - S200
  • [32] 68Ga-DOTATATE PET/CT to predict response to peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumours (NETs).
    Sharma, Rohini
    Wang, Wai Meng
    Evans, Joanne
    Yusuf, Siraj
    Ai-Nahhas, Adil
    Mauri, Francesco
    Barwick, Tara
    Aboagye, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] Correlation Between 68Ga-DOTANOC Uptake and Clinical Evolution After Peptide Receptor Radionuclide Therapy (PRRNT)
    Sampaio, I. L.
    Duarte, H.
    Santos, A.
    Violante, L.
    Teixeira, J.
    Costa, L.
    Lopes, F.
    Soares, O.
    Couto, J.
    Ruiz, I.
    Pereira, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S224 - S224
  • [34] Can PET/CT 68Ga-DOTA-peptides uptake predict the absorbed dose in peptide receptor radionuclide therapy (PRRT)?
    Filice, A.
    Fioroni, F.
    Grassi, E.
    Tartaglione, A.
    Fraternali, A.
    Asti, M.
    Carnaghi, C.
    Fazio, N.
    Frasoldati, A.
    Versari, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S224 - S224
  • [35] 68Ga-DOTANOC PET/CT and Head and Neck Paragangliomas. Evaluation of Response to Peptide Receptor Radionuclide Therapy (PRRNT)
    Lopes, F.
    Sampaio, I. L.
    Estevao, R.
    Monteiro, E.
    Violante, L. S.
    Teixeira, J. P.
    Costa, L.
    Coutinho, T. A.
    Soares, O.
    Duarte, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S458 - S458
  • [36] 68Ga-DOTA-NOC PET and Peptide Receptor Radionuclide Therapy in Management of Bilateral Ovarian Metastases from Gastrointestinal Carcinoid
    Singla, Suhas
    Gupta, Santosh
    Reddy, Rama Mohan
    Durgapal, Prashant
    Bal, C. S.
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (12) : 1202 - 1206
  • [37] Glucagon-Like Peptide-1 Receptor-Targeted PET/CT With 68Ga-HBED-CC-Exendin-4 in Localizing Insulinoma
    Li, Linlin
    Wang, Guochang
    Wang, Jiarou
    Ma, Heng
    Chen, Jingci
    Wang, Rongxi
    Pan, Qingqing
    Hong, Haiyan
    Jin, Wenbin
    Kung, Hank F.
    Zhu, Lin
    Luo, Yaping
    Zhu, Zhaohui
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (01) : 38 - 43
  • [38] Management of neuroendocrine tumours of the rectum (rNET) with Ga-68 somatostatin receptor PET/CT (SR-PET/CT) and Peptide Receptor Radionuclide Therapy (PRRT)
    Prasad, V.
    Kaemmerer, D.
    Hommann, M.
    Hoersch, D.
    Zachert, C.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S201 - S201
  • [39] Ga-68 somatostatin receptor PET/CT (SR-PET/CT) and peptide receptor radionuclide therapy (PRRT) for management of neuroendocrine tumors of the rectum (rNET)
    Prasad, V.
    Kaemmerer, D.
    Hoersch, D.
    Hommann, M.
    Zachert, C.
    Baum, R. P.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [40] Comparison of 18F-DOPA and 68Ga-DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy
    Veenstra, E.
    Brouwers, A. H.
    de Groot, D. A.
    Hofland, J.
    Walenkamp, A. M.
    Brabander, T.
    Wouter, Z. T.
    Noordzij, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S118 - S119
12345